Showing results (61-70 of 363) with videos related to
Sort By:
Pageof 37
Blood|March 12, 2014
How I treat the peripheral T-cell lymphomasAlison J Moskowitz, Matthew A Lunning, Steven M HorwitzCancer Journal (Sudbury, Mass.)|September 26, 2012
Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for longAlison J Moskowitz, Matthew A Lunning, Steven M HorwitzCurrent Treatment Options in Oncology|June 10, 2023
Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging DirectionsRobert Stuver, Steven M Horwitz, Zachary D Epstein-PetersonBlood|February 2, 2024
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)Alison J Moskowitz, Robert N Stuver, Steven M HorwitzCurrent Opinion in Oncology|August 23, 2002
Hepatitis viruses and hepatocellular carcinoma in HIV-infected patientsAvram J Smukler, Lee RatnerAntimicrobial Agents and Chemotherapy|February 24, 2011
Integrase inhibitors effective against human T-cell leukemia virus type 1Muhammad Esa Seegulam, Lee RatnerViruses|October 14, 2011
Targeting HTLV-1 activation of NFκB in mouse models and ATLL patientsDaniel A Rauch, Lee RatnerEbiomedicine|July 31, 2019
Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphomaJared M Andrews, Jennifer A Schmidt, Kenneth R Carson, et al.Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Current treatment of peripheral T-cell lymphomaSteven M Horwitz, Bertrand Coiffier, Eric D Hsi, et al.Cancer Treatment and Research|January 1, 2019
Angioimmunoblastic T-Cell LymphomaMariko Yabe, Ahmet Dogan, Steven M Horwitz, et al.Pageof 37